BMJ.org: Research News Benzodiazepines may be linked to Alzheimer’s disease, study finds

Research News

Benzodiazepines may be linked to Alzheimer’s disease, study finds

BMJ 2014; 349 doi: http://dx.doi.org/10.1136/bmj.g5555 (Published 10 September 2014)Cite this as: BMJ 2014;349:g5555

Get access to this article and to all of thebmj.com for 14 days.

Sign up today for a 14 day free trial.
Access to the full version of this article requires a subscription payment.

Please login or subscribe below.

  1. Zosia Kmietowicz

Author affiliations

Taking benzodiazepines is associated with an increased risk of developing Alzheimer’s disease, particularly in long term users, a study has found.

Benzodiazepine use has long been associated with an increased risk of Alzheimer’s disease, although whether this association is causal remains unclear. To try to better understand the association, a team of researchers from France and Canada used data from the Quebec health insurance programme database (RAMQ) to track the development of Alzheimer’s in a sample of elderly residents living in Quebec, Canada, who had been prescribed benzodiazepines.1

Over a period of at least six years they identified 1796 cases of Alzheimer’s disease. They then compared these cases …

Maurice Preter, MD

About Maurice Preter MD

Maurice Preter, MD is a European and U.S. educated psychiatrist, psychotherapist, psychopharmacologist, neurologist, and medical-legal expert in private practice in Manhattan. He is also the principal of Fifth Avenue Concierge Medicine, PLLC, a medical concierge service and health advisory for select individuals and families.
This entry was posted in Aging, China, Complementary - Alternative Medicine, Events, Forensic Neuropsychiatry, International And Concierge Medicine, keto, Psychiatry/Neurology and tagged , , , , , . Bookmark the permalink.